BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilcock A, Charlesworth S, Prentice W, Selby P, Mckenna M, Cripps S, Considine A, Orr A, Wright M, Mihalyo M, Oxberry S. Prescribing in Chronic Severe Hepatic Impairment. Journal of Pain and Symptom Management 2019;58:515-37. [DOI: 10.1016/j.jpainsymman.2019.04.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Waterman BL, Ramsey SU, Whitsett MP, Patel AA, Radcliff JA, Kotler DL, Winters AC, Woodrell CD, Ufere NN, Serper M, Walling AM, Jones CA, Kelly SG. Top Ten Tips Palliative Care Clinicians Should Know About End-Stage Liver Disease. J Palliat Med 2021;24:924-31. [PMID: 33733875 DOI: 10.1089/jpm.2021.0097] [Reference Citation Analysis]
2 Patel AA, Woodrell C, Ufere NN, Hansen L, Tandon P, Verma M, Lai J, Pinotti R, Rakoski M; Palliative Care Education, Advocacy, and Research in Liver Disease (PEARL) Workgroup and the AASLD Public Health / Healthcare Delivery Special Interest Group (SIG). Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach. Hepatol Commun 2021;5:1469-80. [PMID: 34510839 DOI: 10.1002/hep4.1743] [Reference Citation Analysis]
3 Ostroumova OD, Pereverzev AP. Hepatic impairment as a risk factor of adverse drug reactions. Consilium Medicum 2021;23:939-48. [DOI: 10.26442/20751753.2021.12.201234] [Reference Citation Analysis]